Sun Pharma Pharmaceuticals

Brand Origin and Early History

Sun Pharmaceutical Industries Limited, widely known as Sun Pharma, was founded in 1983 by Dilip Shanghvi in Vapi, Gujarat, India. Initially starting with just five products to treat psychiatry ailments, the company has grown exponentially over four decades to become the largest pharmaceutical company in India and a dominant force in the global generic drug market.

Global Manufacturing and Operations

Today, Sun Pharma operates a massive global network of 41 manufacturing facilities spread across six continents. While its primary manufacturing base remains in India, it has significant production sites in the United States, Canada, Brazil, Mexico, and various countries in Europe and Asia. This diverse manufacturing footprint allows the company to supply high-quality, affordable medicines to approximately 100 countries worldwide.

Ownership and Strategic Growth

Sun Pharma is a publicly traded company listed on the Indian stock exchanges, with the founder, Dilip Shanghvi, and his family remaining the primary promoters. The company's growth has been fueled by several high-profile acquisitions, most notably the 2014 purchase of Ranbaxy Laboratories, which solidified its position as a global leader in generic and specialty pharmaceuticals. The company continues to invest heavily in Research and Development, focusing on complex generics and innovative specialty medicines in areas such as dermatology and ophthalmology.